However, CD11b+ macrophages and CD11c+ DCs were reduced in the spleens of patients with COVID-19 (Supplementary Figure 3), suggesting that the responses of CD11b+ macrophages and CD11c+ DCs to SARS-CoV-2 might be transferred from the spleen to the infected site or other damaged sites. This evidence concerns the gene ITGAM and COVID-19.